Incidence of Viral Hepatitis D Relapses Upon Discontinuation of Bulevirtide in Patients With Chronic Hepatitis D and Negative HDV RNA
CompletedOBSERVATIONAL
Enrollment
24
Participants
Timeline
Start Date
September 1, 2023
Primary Completion Date
February 28, 2025
Study Completion Date
February 28, 2025
Conditions
Chronic Hepatitis D
Trial Locations (1)
125008
Center of Target Therapy, Moscow
All Listed Sponsors
lead
Center of target therapy
OTHER
NCT06121427 - Incidence of Viral Hepatitis D Relapses Upon Discontinuation of Bulevirtide in Patients With Chronic Hepatitis D and Negative HDV RNA | Biotech Hunter | Biotech Hunter